NeuroBo Pharmaceuticals(NRBO) - Prospectus(update)

TABLE OF CONTENTS As filed with the Securities and Exchange Commission on January 12, 2026 Registration No. 333-292581 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Hyung Heon Kim President, Chief Executive Officer and Director 545 Concord Avenue, Suite 210 Cambridge, Massachusetts 02138 (857) 702-9600 (Name, address, including zip code, and telephone number, including area code, of agent for servic ...